Deciphera Pharmaceuticals Profit Margin

Deciphera Pharmaceuticals (DCPH) currently reports a profit margin of -108.87% as of March 2024. That compares with -131.38% in the prior-year period — up 17.1% year over year. That is below the Healthcare sector average of 14.34%. Use the charts on this page to explore Deciphera Pharmaceuticals's profit margin history and peer comparisons.

Deciphera Pharmaceuticals's profit margin increased from -131.38% to -108.87% — a 17.1% year-over-year increase (period ending March 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Deciphera Pharmaceuticals's profit margin of -108.87% is lower than the Healthcare sector average of 14.34%. That is roughly 858.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Deciphera Pharmaceuticals's current -108.87% should be judged against Healthcare norms (sector average: 14.34%) and against DCPH's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of -108.87%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 14.34%. From there, open related valuation or income-statement pages for Deciphera Pharmaceuticals, and consider following DCPH for alerts when major investors trade the stock.